As of March 2026 Iovance Biotherapeutics has a market cap of โน204.76 Billion. This makes Iovance Biotherapeutics the world's 4463th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Mar 9th, 2026 the market cap of Iovance Biotherapeutics was reported to be: